A highly-sensitive anti-Müllerian hormone assay improves analysis of ovarian function following chemotherapy for early breast cancer
Open Access
- 1 September 2014
- journal article
- Published by Elsevier in European Journal of Cancer
- Vol. 50 (14) , 2367-2374
Abstract
No abstract availableKeywords
Funding Information
- MRC (G1100357)
This publication has 35 references indexed in Scilit:
- The physiology and clinical utility of anti-Müllerian hormone in womenHuman Reproduction Update, 2014
- Assessment of the Effect of Chemotherapy on Ovarian Function in Women With Breast CancerJournal of Clinical Oncology, 2007
- The effects of chemotherapy and long-term gonadotrophin suppression on the ovarian reserve in premenopausal women with breast cancerHuman Reproduction, 2006
- Incidence, Time Course, and Determinants of Menstrual Bleeding After Breast Cancer Treatment: A Prospective StudyJournal of Clinical Oncology, 2006
- Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17JNCI: Journal of the National Cancer Institute, 2005
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Depot testosterone with etonogestrel implants result in induction of azoospermia in all men for long-term contraceptionHuman Reproduction, 2004
- Regulation of ovarian function: the role of anti-Mullerian hormoneReproduction, 2002
- Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer.Journal of Clinical Oncology, 1996
- Measurement of dimeric inhibin B throughout the human menstrual cycle.The Journal of Clinical Endocrinology & Metabolism, 1996